Company AB Science

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-19 EDT			5-day change	1st Jan Change
0.8950 ^EUR	+5.17%		+0.56%	-41.73%

06-18	AB Science Secures US Patent for Prostate Cancer Therapy	MT
06-18	AB Science Secures New U.S. Patent for Masitinib

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 36

Sales by Activity: AB Science

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Pharmaceuticals	1.58M	1.61M	958K	970K	1.07M

See all business segments

Executive Committee: AB Science

Manager	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	2001-07-10
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Renaud Sassi BRD	Director/Board Member	-	2021-06-26

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Jean-Claude Marian 10.41 %	6,888,610	10.41 %	8 M €
UBS Wealth Management SGIIC SA 0.004684 %	3,100	0.004684 %	3 487 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	33 313 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 496 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	+5.17%	+0.56%	-22.17%	-80.13%	78.57M
MERCK & CO., INC.	-1.36%	-4.35%	+44.03%	+3.30%	281B
MERCK KGAA	-0.11%	-0.26%	+20.49%	-14.40%	66.27B
KYOWA KIRIN CO., LTD.	+1.30%	+5.71%	+2.24%	-7.88%	8.24B
HALOZYME THERAPEUTICS, INC.	-0.03%	-1.37%	+29.80%	+98.29%	8.13B
SK BIOPHARMACEUTICALS CO., LTD.	-1.92%	-1.02%	-6.35%	+4.44%	4.45B
YUHAN CORPORATION	-2.69%	-1.42%	-26.97%	+36.12%	3.71B
BETTA PHARMACEUTICALS CO., LTD.	+8.33%	+2.08%	+0.22%	+12.14%	3.42B
SUPERNUS PHARMACEUTICALS, INC.	+1.84%	-0.07%	+37.48%	+32.32%	2.58B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-1.01%	-2.64%	+5.02%	-26.66%	1.92B
Average	+0.95%	-1.30%	+8.38%	+5.75%	38B
Weighted average by Cap.	-0.96%	-4.30%	+36.78%	+2.45%